QQ客服 官方微博 反馈留言

	Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms
	Kang Jingjing; Ning Matthew S; Feng Han; Li Hongqi; Bahig Houda; Brooks Eric D; Welsh James W; Ye Rui; Miao Hongyu; Chang Joe Y
	2019
ISSN号	1879-355X
DOI	10.1016/j.ijrobp.2019.09.037
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6335868
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Kang Jingjing,Ning Matthew S,Feng Han,et al. Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms[J],2019.
APA	Kang Jingjing.,Ning Matthew S.,Feng Han.,Li Hongqi.,Bahig Houda.,...&Chang Joe Y.(2019).Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms..
MLA	Kang Jingjing,et al."Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms".(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。